As per a market report by Reportlinker, the worldwide highly potent active pharmaceutical ingredient- HPAPI sector is anticipated to breach the $34.04 billion mark by 2026 at a CAGR of around 8.5%.
HPAPIs are substances that cause a biological response even at extremely low doses.It is well to be noted that cytotoxic substances as well as sex hormones such as oestrogen are considered as significant examples of HPAPIs.
Apparently, last year, it was North America that happened to be the biggest market for HPAPI. The middle east as per the report is expected to be the fastest growing region in the forecast period.
Factors that Influence the HPAPI Market
The report has observed that the inflation caused by the recent war has led to economic sanctions on goods and services across multiple nations. This has gone on to increase the prices of commodities as well as supply chain disruptions.
With increasing number of cancer cases, research has found that the surge in cancer drug sales has contributed to the growth of the HPAPI market. The rising cancer incidences have resulted in more R&D on anticancer drugs, hence propelling the demand for HPAPIs.
As per a report by the International Agency for Research on Cancer and the World Health Organization, the burden of cancer is expected to surge by 29.5 million new cases and around 16.4 million deaths by 2040 around the world. Because of the growing instances of cancer cases, the HPAPI market is going to have an upsurge in revenues. The report states that firms are planning on strategies to expand their existing production facilities as well as go ahead with mergers and acquisitions so as to maintain their position in the market.
A new $65 million facility that was opened in the US last year in June to exclusively manufacture HPAPIs with a cancer treatment emphasis is a significant example in this regard.
Challenges in the manufacturing of HPAPIs
These substances come with prominent handling challenges, including specialised equipment requirements so as to avoid incidences of cross-contamination and also ensure operator and environment safety. Besides, the appropriate process design need, continuous tech evolution and industry benchmarks, and exclusively specialised containment facilities in order to maintain the safety of employees mean that a large amount of investment is needed, which is one of the factors hindering the growth of the HPAPI market.
